Please enable JavaScript to continue using this application.

Compare $RCKT vs $SABS | Chartloom

Compare

$RCKT vs $SABS

Rocket Pharmaceuticals Inc · SAB Biotherapeutics Inc

RCKT

Rocket Pharmaceuticals Inc

SABS

SAB Biotherapeutics Inc

Compare $RCKT vs $SABS

Comparing Rocket Pharmaceuticals Inc and SAB Biotherapeutics Inc

RCKTRocket Pharmaceuticals Inc

SABSSAB Biotherapeutics Inc

RCKTRocket Pharmaceuticals Inc

Market cap

$280M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

34.18x

Rev growth (TTM)

—

YTD performance

-26.0%

52W performance

-24.5%

FCF yield

-61.0%

SABSSAB Biotherapeutics Inc

Market cap

$228M

P/E (TTM)

20.43x

Forward P/E (NTM)

—

Forward P/S (NTM)

—

Rev growth (TTM)

—

YTD performance

-21.0%

52W performance

27.4%

FCF yield

-25.2%

Add ticker

Add up to 1 more ticker to compare

Relative performance

Each ticker starts at 100. 110 means +10% from the start of this window — not a $110 share price.

RCKT

SABS

Detailed metrics comparison

RCKT

Rocket Pharmaceuticals Inc

SABS

SAB Biotherapeutics Inc

Market Cap

RCKT$280M

SABS$228M

Enterprise Value

RCKT$76M

SABS$223M

Price

RCKT$2.56

SABS$2.98

P/E Ratio

RCKTN/A

SABS20.43x

P/S Ratio

RCKT0.00x

SABS204.97x

EV/Sales

RCKT0.00x

SABS201.14x

EV/EBITDA

RCKT8.60x

SABS0.00x

P/B Ratio

RCKT0.76x

SABS1.26x

P/FCF Ratio

RCKTN/A

SABSN/A

EV/FCF

RCKT-0.45x

SABS-3.88x

PEG Ratio

RCKTN/A

SABSN/A

Forward P/E (NTM)

RCKTN/A

SABSN/A

Forward P/S (NTM)

RCKT34.18x

SABSN/A

Revenue (TTM)

RCKT$0

SABS$0

Revenue Growth (YoY)

RCKTN/A

SABSN/A

Forward Rev Growth

RCKT833.4%

SABS13369.8%

Gross Margin (TTM)

RCKT0.0%

SABS0.0%

Operating Margin (TTM)

RCKT0.0%

SABS0.0%

EBITDA Margin (TTM)

RCKT0.0%

SABS0.0%

Net Margin (TTM)

RCKT0.0%

SABS0.0%

FCF Margin (TTM)

RCKTN/A

SABSN/A

Net Income (TTM)

RCKT$-17M

SABS$2M

FCF (TTM)

RCKT$-171M

SABS$-57M

EPS (TTM)

RCKT-$0.15

SABS$0.00

ROE (TTM)

RCKT-576.0%

SABS15.2%

ROA (TTM)

RCKT-490.0%

SABS12.5%

ROIC (TTM)

RCKT-538.0%

SABS14.6%

Cash

RCKT$225M

SABS$8M

Debt

RCKT$21M

SABS$3M

Net Cash/Debt

RCKT$203M

SABS$5M

Current Ratio (TTM)

RCKT9.24x

SABS9.22x

Quick Ratio (TTM)

RCKT9.06x

SABS8.93x

Debt/Equity (TTM)

RCKT0.06x

SABS0.01x

Debt/Assets (TTM)

RCKT0.0%

SABS0.0%

Interest Coverage (TTM)

RCKTN/A

SABSN/A

Net Debt/EBITDA (TTM)

RCKT0.00x

SABS0.00x

Beta

RCKT0.48

SABS0.80

52W Performance

RCKT-24.5%

SABS27.4%

YTD Performance

RCKT-26.0%

SABS-21.0%

% from 52W High

RCKT-53.0%

SABS-42.1%

% from 52W Low

RCKT5.8%

SABS41.9%

Asset Turnover (TTM)

RCKT0.00x

SABS0.02x

FCF Yield (TTM)

RCKT-61.0%

SABS-25.2%

Earnings Yield (TTM)

RCKT-6.2%

SABS1.1%

Dividend Yield (TTM)

RCKTN/A

SABSN/A

Rule of 40

RCKT0.0

SABS0.0

EV/GP/RG

RCKTN/A

SABSN/A

Ticker research

View RCKT research View SABS research

Metric	RCKT Rocket Pharmaceuticals Inc	SABS SAB Biotherapeutics Inc
Market & Valuation
Market Cap	$280M	$228M
Enterprise Value	$76M	$223M
Price	$2.56	$2.98
P/E Ratio	N/A	20.43x
P/S Ratio	0.00x	204.97x
EV/Sales	0.00x	201.14x
EV/EBITDA	8.60x	0.00x
P/B Ratio	0.76x	1.26x
P/FCF Ratio	N/A	N/A
EV/FCF	-0.45x	-3.88x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	34.18x	N/A
Revenue & Growth
Revenue (TTM)	$0	$0
Revenue Growth (YoY)	N/A	N/A
Forward Rev Growth	833.4%	13369.8%
Profitability
Gross Margin (TTM)	0.0%	0.0%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	0.0%	0.0%
Net Margin (TTM)	0.0%	0.0%
FCF Margin (TTM)	N/A	N/A
Net Income (TTM)	$-17M	$2M
FCF (TTM)	$-171M	$-57M
EPS (TTM)	-$0.15	$0.00
ROE (TTM)	-576.0%	15.2%
ROA (TTM)	-490.0%	12.5%
ROIC (TTM)	-538.0%	14.6%
Financial Health
Cash	$225M	$8M
Debt	$21M	$3M
Net Cash/Debt	$203M	$5M
Current Ratio (TTM)	9.24x	9.22x
Quick Ratio (TTM)	9.06x	8.93x
Debt/Equity (TTM)	0.06x	0.01x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	0.48	0.80
52W Performance	-24.5%	27.4%
YTD Performance	-26.0%	-21.0%
% from 52W High	-53.0%	-42.1%
% from 52W Low	5.8%	41.9%
Efficiency & Yields
Asset Turnover (TTM)	0.00x	0.02x
FCF Yield (TTM)	-61.0%	-25.2%
Earnings Yield (TTM)	-6.2%	1.1%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	0.0	0.0
EV/GP/RG	N/A	N/A
Ticker research	View RCKT research	View SABS research

Valuation

P/E Ratio

SABS

20.43x

P/S Ratio

RCKT

0.00x

SABS

204.97x

EV/FCF

SABS

-3.88x

RCKT

-0.45x

Growth & revenue

Forward Revenue Growth

SABS

13369.8%

RCKT

833.4%

Profitability & performance

Gross Margin

RCKT

0.0%

SABS

0.0%

ROE

SABS

15.2%

RCKT

-576.0%

FCF Yield %

SABS

-25.2%

RCKT

-61.0%

52-Week Performance

SABS

27.4%

RCKT

-24.5%

Detailed metrics comparison

RCKT

Rocket Pharmaceuticals Inc

SABS

SAB Biotherapeutics Inc

Market Cap

RCKT$280M

SABS$228M

Enterprise Value

RCKT$76M

SABS$223M

Price

RCKT$2.56

SABS$2.98

P/E Ratio

RCKTN/A

SABS20.43x

P/S Ratio

RCKT0.00x

SABS204.97x

EV/Sales

RCKT0.00x

SABS201.14x

EV/EBITDA

RCKT8.60x

SABS0.00x

P/B Ratio

RCKT0.76x

SABS1.26x

P/FCF Ratio

RCKTN/A

SABSN/A

EV/FCF

RCKT-0.45x

SABS-3.88x

PEG Ratio

RCKTN/A

SABSN/A

Forward P/E (NTM)

RCKTN/A

SABSN/A

Forward P/S (NTM)

RCKT34.18x

SABSN/A

Revenue (TTM)

RCKT$0

SABS$0

Revenue Growth (YoY)

RCKTN/A

SABSN/A

Forward Rev Growth

RCKT833.4%

SABS13369.8%

Gross Margin (TTM)

RCKT0.0%

SABS0.0%

Operating Margin (TTM)

RCKT0.0%

SABS0.0%

EBITDA Margin (TTM)

RCKT0.0%

SABS0.0%

Net Margin (TTM)

RCKT0.0%

SABS0.0%

FCF Margin (TTM)

RCKTN/A

SABSN/A

Net Income (TTM)

RCKT$-17M

SABS$2M

FCF (TTM)

RCKT$-171M

SABS$-57M

EPS (TTM)

RCKT-$0.15

SABS$0.00

ROE (TTM)

RCKT-576.0%

SABS15.2%

ROA (TTM)

RCKT-490.0%

SABS12.5%

ROIC (TTM)

RCKT-538.0%

SABS14.6%

Cash

RCKT$225M

SABS$8M

Debt

RCKT$21M

SABS$3M

Net Cash/Debt

RCKT$203M

SABS$5M

Current Ratio (TTM)

RCKT9.24x

SABS9.22x

Quick Ratio (TTM)

RCKT9.06x

SABS8.93x

Debt/Equity (TTM)

RCKT0.06x

SABS0.01x

Debt/Assets (TTM)

RCKT0.0%

SABS0.0%

Interest Coverage (TTM)

RCKTN/A

SABSN/A

Net Debt/EBITDA (TTM)

RCKT0.00x

SABS0.00x

Beta

RCKT0.48

SABS0.80

52W Performance

RCKT-24.5%

SABS27.4%

YTD Performance

RCKT-26.0%

SABS-21.0%

% from 52W High

RCKT-53.0%

SABS-42.1%

% from 52W Low

RCKT5.8%

SABS41.9%

Asset Turnover (TTM)

RCKT0.00x

SABS0.02x

FCF Yield (TTM)

RCKT-61.0%

SABS-25.2%

Earnings Yield (TTM)

RCKT-6.2%

SABS1.1%

Dividend Yield (TTM)

RCKTN/A

SABSN/A

Rule of 40

RCKT0.0

SABS0.0

EV/GP/RG

RCKTN/A

SABSN/A

Ticker research

View RCKT research View SABS research

Metric	RCKT Rocket Pharmaceuticals Inc	SABS SAB Biotherapeutics Inc
Market & Valuation
Market Cap	$280M	$228M
Enterprise Value	$76M	$223M
Price	$2.56	$2.98
P/E Ratio	N/A	20.43x
P/S Ratio	0.00x	204.97x
EV/Sales	0.00x	201.14x
EV/EBITDA	8.60x	0.00x
P/B Ratio	0.76x	1.26x
P/FCF Ratio	N/A	N/A
EV/FCF	-0.45x	-3.88x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	34.18x	N/A
Revenue & Growth
Revenue (TTM)	$0	$0
Revenue Growth (YoY)	N/A	N/A
Forward Rev Growth	833.4%	13369.8%
Profitability
Gross Margin (TTM)	0.0%	0.0%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	0.0%	0.0%
Net Margin (TTM)	0.0%	0.0%
FCF Margin (TTM)	N/A	N/A
Net Income (TTM)	$-17M	$2M
FCF (TTM)	$-171M	$-57M
EPS (TTM)	-$0.15	$0.00
ROE (TTM)	-576.0%	15.2%
ROA (TTM)	-490.0%	12.5%
ROIC (TTM)	-538.0%	14.6%
Financial Health
Cash	$225M	$8M
Debt	$21M	$3M
Net Cash/Debt	$203M	$5M
Current Ratio (TTM)	9.24x	9.22x
Quick Ratio (TTM)	9.06x	8.93x
Debt/Equity (TTM)	0.06x	0.01x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	0.48	0.80
52W Performance	-24.5%	27.4%
YTD Performance	-26.0%	-21.0%
% from 52W High	-53.0%	-42.1%
% from 52W Low	5.8%	41.9%
Efficiency & Yields
Asset Turnover (TTM)	0.00x	0.02x
FCF Yield (TTM)	-61.0%	-25.2%
Earnings Yield (TTM)	-6.2%	1.1%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	0.0	0.0
EV/GP/RG	N/A	N/A
Ticker research	View RCKT research	View SABS research